raises $25 million in series A funding round for cancer diagnosis through computer vision — 3 insights

Written by Shayna Korol | February 06, 2018 | Print  |

Healthcare startup raised $25 million for its work in cancer diagnosis through computer vision trained with clinical imaging data, according to VentureBeat. also signed an agreement with New York City-based Memorial Sloan Kettering Cancer Center to gain access to its database of 25 million pathology slides.

Here are three things to know:


1. The company's deep learning models will also use treatment and genomics datasets.'s initial work will center on detecting breast, prostate and other major cancers.


2. Thomas Fuchs, PhD, founded Dr. Fuchs is the director of computational pathology at the Warren Alpert Center for Digital and Computational Pathology at Memorial Sloan Kettering. Dr. Fuchs said that the startup is working to develop technology to aid, not replace, pathologists.


3. Breyer Capital led the $25 million series A funding round. currently has five employees and plans to use some of its funding to hire at least 20 additional employees.


More articles on medical imaging:

7D Surgical finishes its greatest financing round — 4 insights

Google-owned DeepMind develops AI algorithm to diagnose optical diseases

South Florida medical imaging center mammograms may be invalid, FDA warns: 4 things to know

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months